SCHEMBL25530705

SCHEMBL25530705

CC(C)(C)OC(=O)/N=C\C1CCC[C@H](c2nnc3cccnn23)C1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.30
LRRK2 Q5S007 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25530031 0.82
SCHEMBL25530000 0.82 MEN1 (0.35) LRRK2
SCHEMBL25537224 0.79 MAPK13 (0.36)
SCHEMBL30397355 0.78 KMT2A (0.46)
SCHEMBL25530098 0.75
SCHEMBL25530096 0.75
SCHEMBL25537227 0.74 MAPK13 (0.34)
SCHEMBL8260069 0.72 GPR119 (0.48)
SCHEMBL24438706 0.67 CHRM2 (0.36)
SCHEMBL25530656 0.67 KMT2A (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023091726-A1 INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) SYROS PHARMACEUTICALS, INC. (US) 2023-05-25 WO disclosed